Addiction to protein kinase Cɩ due to PRKCI gene amplification can be exploited for an aptamer-based targeted therapy in ovarian cancer
Open Access
- 21 August 2020
- journal article
- research article
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 5 (1) , 1-11
Abstract
PRKCI, the gene for protein kinase Cι (PKCι), is frequently amplified in ovarian cancer and recent studies have shown that PKCι participates in ovary tumorigenesis. However, it is unknown whether PKCι is differentially involved in the growth/survival between PRKCI-amplified and non-amplified ovarian cancer cells. In this study, we analyzed ovarian cancer patient dataset and revealed that PRKCI is the only PKC family member significantly amplified in ovarian cancer and PRKCI amplification is associated with higher PKCι expression. Using a panel of ovarian cancer cell lines, we found that abundance of PKCι is generally associated with PRKCI amplification. Interestingly, silencing PKCι led to apoptosis in PRKCI-amplified ovarian cancer cells but not in those without PRKCI amplification, thus indicating an oncogenic addiction to PKCɩ in PRKCI-amplified cells. Since small-molecule inhibitors characterized to selectively block atypical PKCs did not offer selectivity nor sensitivity in PRKCI-amplified ovarian cancer cells and were even cytotoxic to non-cancerous ovary surface or fallopian tube epithelial cells, we designed an EpCAM aptamer-PKCι siRNA chimera (EpCAM-siPKCι aptamer). EpCAM-siPKCι aptamer not only effectively induced apoptosis of PRKCI-amplified ovarian cancer cells but also greatly deterred intraperitoneal tumor development in xenograft mouse model. This study has demonstrated a precision medicine-based strategy to target a subset of ovarian cancer that contains PRKCI amplification and shown that the EpCAM aptamer-delivered PKCι siRNA may be used to suppress such tumors.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (CA 187152, CA 222467)
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 37 references indexed in Scilit:
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion moleculeCancer Science, 2011
- An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4 + T Cell Decline in Humanized MiceScience Translational Medicine, 2011
- Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complexCell Death & Differentiation, 2009
- Identification of a Small Molecule with Synthetic Lethality for K-Ras and Protein Kinase C IotaCancer Research, 2008
- Amplicon profiles in ovarian serous carcinomasInternational Journal of Cancer, 2007
- Epidermal growth factor receptor mutations in lung cancerNature Reviews Cancer, 2007
- A Novel Small-Molecule Inhibitor of Protein Kinase Cι Blocks Transformed Growth of Non–Small-Cell Lung Cancer CellsCancer Research, 2006
- Analysis of ovarian cancer cell lines using array‐based comparative genomic hybridizationThe Journal of Pathology, 2004
- The significance of oncogene amplification in primary breast cancerInternational Journal of Cancer, 1989